Covered recipient · General Payments record
NATASHA SPARROW
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2018–2024
$2,098.60
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.02 | 17 |
| Education | $13.40 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $159.48 | 6 |
| NEUROPACE, INC. | $94.49 | 2 |
| ABBVIE INC. | $93.26 | 3 |
| SK Life Science, Inc. | $43.20 | 2 |
| LivaNova USA, Inc. | $39.28 | 2 |
| PFIZER INC. | $23.72 | 1 |
| Lilly USA, LLC | $20.59 | 1 |
| Neurelis, Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.45 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264579 | CMS |
| ABBVIE INC. | $31.15 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264583 | CMS |
| ABBVIE INC. | $32.66 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264587 | CMS |
| Lilly USA, LLC | $20.59 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135283144 | CMS |
| LivaNova USA, Inc. | $18.87 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152795047 | CMS |
| LivaNova USA, Inc. | $20.41 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152795045 | CMS |
| Neurelis, Inc. | $13.40 | 03/27/2024 | Education | Undisputed | 01/23/2026 | 1145650892 | CMS |
| NEUROPACE, INC. | $77.97 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153274936 | CMS |
| NEUROPACE, INC. | $16.52 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153274990 | CMS |
| PFIZER INC. | $23.72 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131942261 | CMS |
| SK Life Science, Inc. | $21.03 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154115833 | CMS |
| SK Life Science, Inc. | $22.17 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154115855 | CMS |
| UCB, Inc. | $20.83 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332200 | CMS |
| UCB, Inc. | $23.16 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332205 | CMS |
| UCB, Inc. | $23.17 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332209 | CMS |
| UCB, Inc. | $31.43 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332213 | CMS |
| UCB, Inc. | $33.85 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332217 | CMS |
| UCB, Inc. | $27.04 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332222 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.